{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:03:49Z","timestamp":1786122229790,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.placenta.2026.06.011","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:04:54Z","timestamp":1781967894000},"page":"133-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between antiphospholipid syndrome and outcomes of singleton pregnancies conceived via assisted reproductive technology (ART): A Nationwide Inpatient Sample analysis 2005-2020"],"prefix":"10.1016","volume":"182","author":[{"given":"Heng-Kien","family":"Au","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Chen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wei","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Sheng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2026.06.011_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of antiphospholipid syndrome in the general population","volume":"23","author":"Dabit","year":"2022","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.placenta.2026.06.011_bib2","doi-asserted-by":"crossref","first-page":"SI24","DOI":"10.1093\/rheumatology\/kead571","article-title":"Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations","volume":"63","author":"Gaspar","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.placenta.2026.06.011_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.23736\/S0392-0488.18.06152-7","article-title":"Antiphospholipid syndrome and pregnancy","volume":"154","author":"Satta","year":"2019","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"10.1016\/j.placenta.2026.06.011_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5694\/mja2.50262","article-title":"Antiphospholipid syndrome: a clinical review","volume":"211","author":"Mezhov","year":"2019","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.placenta.2026.06.011_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102901","article-title":"Pregnancy outcome predictors in antiphospholipid syndrome: a systematic review and meta-analysis","volume":"20","author":"Walter","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.placenta.2026.06.011_bib6","first-page":"306","article-title":"A retrospective review of antiphospholipid syndrome: a single tertiary centre experience","volume":"79","author":"Yeoh","year":"2024","journal-title":"Med. J. Malaysia"},{"key":"10.1016\/j.placenta.2026.06.011_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/dmcn.15332","article-title":"Assisted reproductive technology: Short- and long-term outcomes","volume":"65","author":"Graham","year":"2023","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.placenta.2026.06.011_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.fertnstert.2014.09.033","article-title":"Impact of assisted reproductive technology on the incidence of multiple-gestation infants: a population perspective","volume":"103","author":"Scholten","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.placenta.2026.06.011_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.20970","article-title":"Risks of placental abruption and preterm delivery in patients undergoing assisted reproduction","volume":"7","author":"Zhang","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.placenta.2026.06.011_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/GCO.0000000000000535","article-title":"The association between assisted reproductive technologies and low birth weight","volume":"31","author":"Reig","year":"2019","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.06.011_bib11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s11239-023-02789-8","article-title":"Management and outcomes of women with antiphospholipid syndrome during pregnancy","volume":"55","author":"Tao","year":"2023","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.placenta.2026.06.011_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13470","article-title":"Antiphospholipid antibodies and pregnancy outcome of assisted reproductive treatment: a systematic review and meta-analysis","volume":"86","author":"Gao","year":"2021","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.placenta.2026.06.011_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2018.08.034","article-title":"Maternal age and risk for adverse outcomes","volume":"219","author":"Sheen","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.06.011_bib14","series-title":"StatPearls [Internet]. Treasure Island (FL)","article-title":"Antiphospholipid syndrome. 2024 may 6","author":"Bustamante","year":"2024"},{"key":"10.1016\/j.placenta.2026.06.011_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0961203319893763","article-title":"Antiphospholipid syndrome and infertility","volume":"29","author":"El Hasbani","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.placenta.2026.06.011_bib16","article-title":"Antiphospholipid syndrome in pregnancy: new and old pathogenetic mechanisms","volume":"24","author":"D'Ippolito","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.placenta.2026.06.011_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.852777","article-title":"Risk of thrombosis, pregnancy morbidity or death in antiphospholipid syndrome","volume":"9","author":"Killian","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.placenta.2026.06.011_bib18","article-title":"Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study","volume":"216","author":"Saccone","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.06.011_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11082298","article-title":"Preeclampsia and the antiphospholipid syndrome","volume":"11","author":"Mayer-Pickel","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.placenta.2026.06.011_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-021-02518-7","article-title":"Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients","volume":"23","author":"Larosa","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.placenta.2026.06.011_bib21","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1007\/s10238-023-01195-x","article-title":"Cluster analysis of antiphospholipid antibodies-associated adverse pregnancy outcome patients: based on a 13-years cohort study","volume":"23","author":"Long","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.placenta.2026.06.011_bib22","series-title":"Clinical and applied thrombosis\/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis\/Hemostasis","article-title":"Anticardiolipin positivity is highly associated with intrauterine growth restriction in women with antiphospholipid syndrome","volume":"26","author":"Xi","year":"2020"},{"key":"10.1016\/j.placenta.2026.06.011_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2021.103315","article-title":"Risk factors for pregnancy morbidity in women with antiphospholipid syndrome","volume":"145","author":"Yang","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.placenta.2026.06.011_bib24","article-title":"Pregnancy outcomes in patients with primary antiphospholipid syndrome: a systematic review and meta-analysis","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.placenta.2026.06.011_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2024.104262","article-title":"Innate and adaptive immune dysregulation in women with recurrent implantation failure","volume":"164","author":"Ebrahimi","year":"2024","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.placenta.2026.06.011_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/iid3.404","article-title":"Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19","volume":"9","author":"Costagliola","year":"2021","journal-title":"Immun. Inflammat. Disease"},{"key":"10.1016\/j.placenta.2026.06.011_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.986893","article-title":"Anticardiolipin and\/or anti-\u03b22-glycoprotein-I antibodies are associated with adverse IVF outcomes","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.placenta.2026.06.011_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260759","article-title":"Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: a systematic review and meta-analysis","volume":"17","author":"Papadimitriou","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2026.06.011_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103101","article-title":"Antiphospholipid antibodies in women with recurrent embryo implantation failure: a systematic review and meta-analysis","volume":"21","author":"Jarne-Borras","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.placenta.2026.06.011_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2022.103674","article-title":"A retrospective study on IVF\/ICSI outcomes in patients with persisted positive of anticardiolipin antibody: effects of low-dose aspirin plus low molecular weight heparin adjuvant treatment","volume":"153","author":"Zhang","year":"2022","journal-title":"J. Reprod. Immunol."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400426003000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400426003000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:45:52Z","timestamp":1786092352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400426003000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S0143400426003000"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2026.06.011","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between antiphospholipid syndrome and outcomes of singleton pregnancies conceived via assisted reproductive technology (ART): A Nationwide Inpatient Sample analysis 2005-2020","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2026.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}